Molecular pattern of a decrease in the rewarding effect of cocaine after an escalating-dose drug regimen

• Published in: Pharmacological reports Vol. 75; no. 1; p. 85
• Main Authors: Kołosowska, Karolina, Lehner, Małgorzata, Skórzewska, Anna, Gawryluk, Aleksandra, Tomczuk, Filip, Sobolewska, Alicja, Turzyńska, Danuta, Liguz-Lęcznar, Monika, Bednarska-Makaruk, Małgorzata, Maciejak, Piotr, Wisłowska-Stanek, Aleksandra
• Format: Journal Article
• Language: English
• Published: Switzerland 01-02-2023
• Subjects: Animals; beta-Endorphin; Cocaine; Cocaine-Related Disorders; Corticosterone; MicroRNAs; Pro-Opiomelanocortin; Rats; Reward; RNA, Messenger; microRNA; HPA axis; Cocaine binge; Neuromodulators; KOR; OX1R
• ISSN: 2299-5684
• DOI: 10.1007/s43440-022-00443-3

Long-term cocaine exposure leads to dysregulation of the reward system and initiates processes that ultimately weaken its rewarding effects. Here, we studied the influence of an escalating-dose cocaine regimen on drug-associated appetitive behavior after a withdrawal period, along with corresponding molecular changes in plasma and the prefrontal cortex (PFC).
We applied a 5 day escalating-dose cocaine regimen in rats. We assessed anxiety-like behavior at the beginning of the withdrawal period in the elevated plus maze (EPM) test. The reinforcement properties of cocaine were evaluated in the Conditioned Place Preference (CPP) test along with ultrasonic vocalization (USV) in the appetitive range in a drug-associated context. We assessed corticosterone, proopiomelanocortin (POMC), β-endorphin, CART 55-102 levels in plasma (by ELISA), along with mRNA levels for D2 dopaminergic receptor (D2R), κ-receptor (KOR), orexin 1 receptor (OX1R), CART 55-102, and potential markers of cocaine abuse: miRNA-124 and miRNA-137 levels in the PFC (by PCR).
Rats subjected to the escalating-dose cocaine binge regimen spent less time in the cocaine-paired compartment, and presented a lower number of appetitive USV episodes. These changes were accompanied by a decrease in corticosterone and CART levels, an increase in POMC and β-endorphin levels in plasma, and an increase in the mRNA for D2R and miRNA-124 levels, but a decrease in the mRNA levels for KOR, OX1R, and CART 55-102 in the PFC.
The presented data reflect a part of a bigger picture of a multilevel interplay between neurotransmitter systems and neuromodulators underlying processes associated with cocaine abuse.